Metronidazole
Metronidazole is a topic covered in the Johns Hopkins ABX Guide.
To view the entire topic, please log in or purchase a subscription.
Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:
-- The first section of this topic is shown below --
INDICATIONS
FDA
FDA
- Anaerobic infections: intra-abdominal infections, skin and skin structure infections, bone and joint infections
- Bacterial septicemia; endocarditis (caused by Bacteroides spp.)
- Gynecologic infections (endometritis, endomyometritis, tubo-ovarian abscess, and postsurgical vaginal cuff infection) in combination with agents active against Gram-negative urogenital flora.
- Lower respiratory tract infections (in combination with another agent with activity against microaerophilic Streptococcus)
- Adjunct treatment for gastritis and duodenal ulcer associated with Helicobacter pylori
- CNS infections (meningitis and brain abscess)
- Treatment of acute intestinal amebiasis and amebic liver abscess
- Treatment of symptomatic and asymptomatic trichomoniasis
- Bacterial vaginosis (vaginal gel)
- Acne rosacea (topical gel)
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Colitis, including C. difficile, Crohn’s flare
- Treatment of giardiasis and dracunculiasis
- Periodontal disease
- Elective colorectal surgery (classified as contaminated or potentially contaminated)
-- To view the remaining sections of this topic, please log in or purchase a subscription --
INDICATIONS
FDA
FDA
- Anaerobic infections: intra-abdominal infections, skin and skin structure infections, bone and joint infections
- Bacterial septicemia; endocarditis (caused by Bacteroides spp.)
- Gynecologic infections (endometritis, endomyometritis, tubo-ovarian abscess, and postsurgical vaginal cuff infection) in combination with agents active against Gram-negative urogenital flora.
- Lower respiratory tract infections (in combination with another agent with activity against microaerophilic Streptococcus)
- Adjunct treatment for gastritis and duodenal ulcer associated with Helicobacter pylori
- CNS infections (meningitis and brain abscess)
- Treatment of acute intestinal amebiasis and amebic liver abscess
- Treatment of symptomatic and asymptomatic trichomoniasis
- Bacterial vaginosis (vaginal gel)
- Acne rosacea (topical gel)
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Colitis, including C. difficile, Crohn’s flare
- Treatment of giardiasis and dracunculiasis
- Periodontal disease
- Elective colorectal surgery (classified as contaminated or potentially contaminated)
There's more to see -- the rest of this entry is available only to subscribers.